Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10

Autor: Ladislav Anděra, Alena Hyršlová Vaculová, Silvie Tománková, Jan Bouchal, Milan Král, Martin Krkoška, Petr Sova, Zuzana Kahounová, Barbora Šafaříková, Gvantsa Kharaishvili, Alois Kozubík, Olga Vondálová Blanářová, Jarmila Herůdková
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Proteomics
Male
Organoplatinum Compounds
Cancer Treatment
lcsh:Medicine
Apoptosis
Synthetic Biotechnology
Mitochondrion
Biochemistry
TNF-Related Apoptosis-Inducing Ligand
Prostate cancer
0302 clinical medicine
Spectrum Analysis Techniques
Medicine and Health Sciences
Cytotoxic T cell
lcsh:Science
Caspase 10
Energy-Producing Organelles
Multidisciplinary
Cell Death
Pharmaceutics
Prostate Cancer
Prostate Diseases
Flow Cytometry
Cell biology
XIAP
Mitochondria
Chemistry
Oncology
Cell Processes
Spectrophotometry
030220 oncology & carcinogenesis
Physical Sciences
Engineering and Technology
Synthetic Biology
Cytophotometry
Cellular Structures and Organelles
medicine.drug
Research Article
Chemical Elements
Biotechnology
BH3 Interacting Domain Death Agonist Protein
Programmed cell death
Urology
Biology
Bioenergetics
Research and Analysis Methods
03 medical and health sciences
Drug Therapy
medicine
Amantadine
Humans
Synthetic Peptides
Platinum
Cisplatin
lcsh:R
Biology and Life Sciences
Cancers and Neoplasms
Prostatic Neoplasms
Cell Biology
medicine.disease
Genitourinary Tract Tumors
030104 developmental biology
Cancer cell
lcsh:Q
Peptides
Zdroj: PLoS ONE
PLoS ONE, Vol 12, Iss 11, p e0188584 (2017)
ISSN: 1932-6203
Popis: Searching for new strategies for effective elimination of human prostate cancer cells, we investigated the cooperative cytotoxic action of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and two platinum-based complexes, cisplatin or LA-12, and related molecular mechanisms. We demonstrated a notable ability of cisplatin or LA-12 to enhance the sensitivity of several human prostate cancer cell lines to TRAIL-induced cell death via an engagement of mitochondrial apoptotic pathway. This was accompanied by augmented Bid cleavage, Bak activation, loss of mitochondrial membrane potential, activation of caspase-8, -10, -9, and -3, and XIAP cleavage. RNAi-mediated silencing of Bid or Bak in Bax-deficient DU 145 cells suppressed the drug combination-induced cytotoxicity, further underscoring the involvement of mitochondrial signaling. The caspase-10 was dispensable for enhancement of cisplatin/LA-12 and TRAIL combination-induced cell death and stimulation of Bid cleavage. Importantly, we newly demonstrated LA-12-mediated enhancement of TRAIL-induced cell death in cancer cells derived from human patient prostate tumor specimens. Our results provide convincing evidence that employing TRAIL combined with cisplatin/LA-12 could contribute to more effective killing of prostate cancer cells compared to the individual action of the drugs, and offer new mechanistic insights into their cooperative anticancer action.
Databáze: OpenAIRE